/
BMGL
$6.79-$0.01 (-0.15%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$10.8M
2M shares
52-week range
$4.60 – $54.60
4% from low
Exchange
NASDAQ
CS
Borrow rate
87.82%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-46.49
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Revenue | $10.7M | $9.7M | $10.1M | $11.3M |
| Cost of revenue | $2.2M | $2.3M | $2.2M | $2.5M |
| Gross profit | $8.5M | $7.4M | $7.8M | $8.8M |
| Gross margin | 79.6% | 75.9% | 77.6% | 77.7% |
| R&D | $0 | $0 | $0 | $0 |
| Operating income | $2.5M | $2.0M | $2.2M | −$2.2M |
| EBITDA | $3.3M | $2.9M | $3.1M | −$11.1M |
| Net income | $2.0M | $1.8M | $2.1M | −$12.1M |
| Net margin | 18.6% | 18.4% | 20.6% | -106.8% |
| EPS (diluted) | 1.07 | 0.96 | 1.14 | -5.16 |
Annual figures · source: Financial Modeling Prep
Peer comparison
Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
www.baselmedical.com- Employees
- 70
- IPO / List date
- Feb 25, 2025
Held by traders on TradeandTell
No one on the platform currently holds BMGL.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BMGL as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-06-22 | 1-for-12reverse |
Recent trades on TradeandTell
No one on the platform has traded BMGL yet.
